Blog

FAETH THERAPEUTICS AND THE GOG FOUNDATION, INC. LAUNCH FIRST PHASE 2 COMBINATION TRIAL FOR SAPANISERTIB-SERABELISIB IN PATIENTS WITH ENDOMETRIAL CANCER In a groundbreaking development in cancer treatment, Faeth Therapeutics, a clinical-stage biotechnology firm, in partnership with The GOG Foundation, Inc, has initiated a Phase 2

In a groundbreaking study from researchers at University of Florida Health, new light is shed on the relationship between diet and lung cancer, a connection that has been largely overlooked in the realm of oncological research. Traditionally, lung cancer has not been classified as a

A cutting-edge breakthrough in car T-cell therapy manufacturing has garnered significant attention within the scientific community. A research team from the Wesley Center for Immunotherapy at the University Hospitals Seidman Cancer Center in Cleveland, Ohio, has developed an innovative CAR T-cell manufacturing process that could

Researchers at Moffitt Cancer Center have made significant strides in enhancing cancer immunotherapy approaches, particularly in targeting melanoma, the most aggressive form of skin cancer. Their groundbreaking study, appearing in the Journal for ImmunoTherapy of Cancer, explores the role of a protein known as macrophage

In the rapidly evolving field of cancer treatment, researchers have made significant strides in developing innovative therapeutic approaches targeting tumors more effectively. A groundbreaking study has revealed a novel strategy involving engineered nanosystems, specifically designed to enhance cancer chemotherapy while simultaneously engaging the immune system.

In a groundbreaking study published in the esteemed journal JAMA Oncology, researchers from Mass General Brigham have challenged the conventional protocol for monitoring Prostate Specific Antigen (PSA) levels post-surgery in patients who have undergone prostatectomy for prostate cancer. Historically, medical practitioners have adhered to a

In a groundbreaking study, researchers have unveiled compelling results from a clinical trial that paves the way for new approaches in treating head and neck squamous cell carcinomas (HNSCCs) through the use of immunotherapy. This innovative strategy inherently focuses on the interplay between various immune

High sugar-sweetened beverage intake has emerged as a significant health concern, particularly in relation to cancer risk. Recent research published in the prestigious journal JAMA Otolaryngology–Head & Neck Surgery sheds light on the association between high consumption of sugar-sweetened beverages and an increased risk of

Cancer remains one of the foremost health crises worldwide, responsible for a staggering number of fatalities annually. The urgent necessity for innovative detection techniques and personalized treatment regimens has never been more pressing. In response to this dire need, City University of Hong Kong (CityUHK)

New research emerging from Edith Cowan University (ECU) has elucidated the potential for regular exercise to substantially alleviate erectile dysfunction in men diagnosed with prostate cancer. This condition, often exacerbated by cancer treatments, poses not only a health concern but also a significant barrier to